Volume 30, Issue 194 (2-2021)
J Mazandaran Univ Med Sci 2021, 30(194): 121-126 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Navaifar M R, Rahimzadeh G, Fahimzad A R, Safar M J, Shamshiri A R, Rezai S, et al . Seroepidemiology of Hepatitis B in Pregnant Women
in Sari, Iran 2018- 2020. J Mazandaran Univ Med Sci 2021; 30 (194) :121-126
URL: http://jmums.mazums.ac.ir/article-1-15639-en.html
URL: http://jmums.mazums.ac.ir/article-1-15639-en.html
Mohammad Reza Navaifar 
, Golnar Rahimzadeh , Ali Reza Fahimzad , Mohammad Jafar Safar , Ahmad Reza Shamshiri , Shaghayegh Rezai , Maedeh Hoseinpour , Faezeh Sadat Movahedi , Mohammad Sadegh Rezai
, Golnar Rahimzadeh , Ali Reza Fahimzad , Mohammad Jafar Safar , Ahmad Reza Shamshiri , Shaghayegh Rezai , Maedeh Hoseinpour , Faezeh Sadat Movahedi , Mohammad Sadegh Rezai
Abstract: (1723 Views)
Background and purpose: Hepatitis B vaccination is recommended in HBsAg-positive mothers to prevent hepatitis B in infants. Mother-to-infant transmission of HBV causes many health problems and it is important to identify HBV positive mothers. This investigation aimed at studying the prevalence of HBV and the immunogenicity of HBV vaccination in pregnant women to prevent HBV at birth in Sari, Iran.
Materials and methods: This descriptive observational study was conducted in pregnant women attending Sari Birth Cohort (SBC) Center, 2018-2020. A total of 1018 samples were investigated for HBV serological markers by enzyme-linked immunosorbent assay (ELISA).
Results: The prevalence of HBV was 1.57% and 46.6% (n=474) of expectant mothers had received HBV vaccine. Immunogenicity of HBV vaccination was 51.9%. HBV prevalence was found to be significantly associated with increase in age and gestational age (P= 0.009 and P= 0.005, respectively). HBV infection in women who were not immunized was significantly associated with family history of HBV and unprotected sex (P= 0.000 and P= 0.008, respectively).
Conclusion: Family history of HBV, maternal age, gestational age, and unprotected intercourse were the risk factors for HBV infection in pregnant women in Sari.
Materials and methods: This descriptive observational study was conducted in pregnant women attending Sari Birth Cohort (SBC) Center, 2018-2020. A total of 1018 samples were investigated for HBV serological markers by enzyme-linked immunosorbent assay (ELISA).
Results: The prevalence of HBV was 1.57% and 46.6% (n=474) of expectant mothers had received HBV vaccine. Immunogenicity of HBV vaccination was 51.9%. HBV prevalence was found to be significantly associated with increase in age and gestational age (P= 0.009 and P= 0.005, respectively). HBV infection in women who were not immunized was significantly associated with family history of HBV and unprotected sex (P= 0.000 and P= 0.008, respectively).
Conclusion: Family history of HBV, maternal age, gestational age, and unprotected intercourse were the risk factors for HBV infection in pregnant women in Sari.
Type of Study: Research(Original) |
Subject:
infection
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
